BlackRock Group’s MediciNova MNOV Stock Holding History

BlackRock Group’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-96,607	Closed	-$709K	–	3036
2016 Q1	$709K	Buy	+96,607	New	+$479K	﹤0.01%	2089

Other funds holding MNOV

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BlackRock Group's MNOV Position: Q2 2016 in Review

BlackRock Group sold out of MediciNova (MNOV) in Q2 2016, closing a stake of 96,607 shares — an estimated $709K sold.

BlackRock Group first reported a position in MNOV in Q1 2016 and held it in 1 quarter. The position peaked at $709K in Q1 2016. 48 funds tracked by Wall St. Rank hold MNOV as of Q2 2016.

BlackRock Group reported no remaining MediciNova position as of Q2 2016 after selling out during the quarter.
BlackRock Group sold 96,607 MediciNova shares in Q2 2016, an estimated $709K.
BlackRock Group first reported a position in MediciNova in Q1 2016 and held it in 1 quarter.
BlackRock Group's MediciNova position peaked at $709K in Q1 2016.
48 funds tracked by Wall St. Rank held MediciNova as of Q2 2016.

Based on BlackRock Group's 13F filing for Q2 2016, filed 10 Aug 2016.